The use of unique device identifiers is intended to improve patient safety by allowing FDA regulators to track devices on a unit level and recall defective products more easily.
The UDIs will be phased in over the next seven years, beginning with high-risk devices like pacemakers and artificial joints.
More Articles on FDA Regulation:
Michigan Bill Calls for FDA Regulation of Medical Apps
The Case for Integrated Clinical Decision Support Software in EMRs
FDA: How to Use Radio-Frequency Wireless Healthcare Devices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
